Nancy Miller-Rich

Insider Reports History

Location
C/O Intercept Pharmaceuticals, Inc., 10 Hudson Yards, 37 Th Fl, New York, NY
Signature
/s/ Scott Bizily as Attorney-in-Fact for Nancy Miller-Rich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nancy Miller-Rich:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aldeyra Therapeutics, Inc. Director Common Stock 922 $9.34K $10.13 Apr 12, 2023 Direct
4D Molecular Therapeutics, Inc. Director Stock Option (Right to Buy) 22.5K Jun 17, 2025 Direct
Aldeyra Therapeutics, Inc. Director Stock Option (Right to Buy) 2.41K Jun 10, 2025 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 Nov 8, 2023 Direct
Kadmon Holdings, Inc. Director Stock Option (right to buy) 0 $5.54 Nov 9, 2021 Direct

Insider Reports Filed by Nancy Miller-Rich

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FDMT 4D Molecular Therapeutics, Inc. Jun 17, 2025 1 $0 4 Jun 20, 2025 Director
ALDX Aldeyra Therapeutics, Inc. Jun 10, 2025 2 $0 4 Jun 12, 2025 Director
ALDX Aldeyra Therapeutics, Inc. Jun 4, 2024 2 $0 4 Jun 6, 2024 Director
FDMT 4D Molecular Therapeutics, Inc. May 21, 2024 1 $0 4 May 23, 2024 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 8 -$578K 4 Nov 13, 2023 Director
ALDX Aldeyra Therapeutics, Inc. Jun 30, 2023 2 $0 4 Jul 5, 2023 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 24, 2023 2 $0 4 May 25, 2023 Director
FDMT 4D Molecular Therapeutics, Inc. May 23, 2023 1 $0 4 May 25, 2023 Director
ALDX Aldeyra Therapeutics, Inc. Jun 7, 2022 2 $0 4 Jun 9, 2022 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 25, 2022 2 $0 4 May 27, 2022 Director
FDMT 4D Molecular Therapeutics, Inc. May 23, 2022 1 $0 4 May 25, 2022 Director
KDMN Kadmon Holdings, Inc. Nov 9, 2021 2 -$768K 4 Nov 9, 2021 Director
ALDX Aldeyra Therapeutics, Inc. Jun 8, 2021 2 $0 4 Jun 10, 2021 Director
ICPT INTERCEPT PHARMACEUTICALS, INC. May 27, 2021 2 $0 4 Jun 1, 2021 Director
FDMT 4D Molecular Therapeutics Inc. May 17, 2021 1 $0 4 May 19, 2021 Director
KDMN Kadmon Holdings, Inc. May 12, 2021 1 $0 4 May 13, 2021 Director
ALDX Aldeyra Therapeutics, Inc. May 3, 2021 2 $10.4K 4 Oct 21, 2024 Director